ArticleChemistry & biodiversity2026
Anticancer Potential of Piericidin A1 and Derivatives Isolated From Streptomyces sp. Associated With Palythoa variabilis From Brazilian Reefs.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Marine holobionts are an important source of bioactive natural products. Building on our previous studies of cytotoxic compounds from zoantharians of the genus Palythoa, we investigated the anticancer potential of bacteria associated with Palythoa variabilis. Ten culturable bacterial strains were isolated and screened for cytotoxic activity against metastatic prostate cancer cells (PC-3/M) using the MTT assay. Among them, the crude extract of strain BRA-035, identified as Streptomyces sp., showed the most promising bioactivity profile and was selected for cytotoxicity-guided fractionation. This approach enabled the isolation of piericidin A1 (1) and the identification of two additional piericidin derivatives (2 and 3). piericidin A1 exhibited strong and selective cytotoxicity, with IC
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.